George P. Vlasuk
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update
George P. Vlasuk, PhD, is a director at Nimbus Therapeutics. He was previously President, CEO, and CSO of Navitor Pharmaceuticals, and he has also served as CEO of Sirtris, a GlaxoSmithKline company. Earlier in his career, he was Vice President of Metabolic Disease and Hemophilia Research at Wyeth Pharmaceuticals, Chief Scientific Officer and Executive Vice President of Research and Development at Corvas International, and he led a research team at Merck focused on cardiovascular medicine discovery programs. He is known for his leadership roles in drug discovery and development and for authoring more than 100 scientific publications and holding 38 issued US and foreign patents.
Updated 19 October 2026
Public sources: nimbustx.com
Why this page exists, and how to correct or remove it
This profile is assembled automatically because George P. Vlasuk appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data